| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Gm Of U.s. | EVP, Gm Of U.s., Commercial Ma | EVP &Gm, North America
1 company
Sablich Kim is an EVP, Gm Of U.s. at JAZZ. Recent filings cover 0 purchases and 9 sales. Those positions are worth an estimated $3.7M at current prices.
Our model assigns Sablich Kim a middling insider score of 54/100, based on 4 past trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +9.3%.
Sablich Kim's largest disclosed position is in JAZZ as EVP, Gm Of U.s., worth about $3.7M. The recent filings there lean toward selling, a net 9,590 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 8, 2023 | JAZZ Jazz Pharmaceuticals Plc | EVP, Gm Of U.s., Commercial Ma | Sell | 3,013 | $139.74 | $421,043.43 | -9.0% | -7.8% | -16.8% | |
| Jun 7, 2022 | JAZZ Jazz Pharmaceuticals Plc | EVP &Gm, North America | Sell | 3,829 | $151.45 | $579,897.75 | -13.4% | -2.4% | -16.9% | |
| Nov 11, 2021 | JAZZ Jazz Pharmaceuticals Plc | EVP &Gm, North America | Sell | 2,748 | $135.01 | $371,000.34 | -11.5% | +7.1% | +10.1% |